IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VANNUCCHI, GUIA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.405
EU - Europa 3.336
AS - Asia 2.842
SA - Sud America 442
AF - Africa 71
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.129
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.191
CN - Cina 942
GB - Regno Unito 839
SG - Singapore 765
IT - Italia 642
DE - Germania 331
SE - Svezia 323
BR - Brasile 270
FR - Francia 221
HK - Hong Kong 192
VN - Vietnam 188
RU - Federazione Russa 173
NL - Olanda 156
IN - India 149
CA - Canada 137
BD - Bangladesh 110
ES - Italia 99
TR - Turchia 87
IE - Irlanda 86
JP - Giappone 83
UA - Ucraina 82
FI - Finlandia 73
KR - Corea 62
ID - Indonesia 56
MX - Messico 51
CO - Colombia 46
DK - Danimarca 44
BE - Belgio 42
CH - Svizzera 37
CL - Cile 34
PL - Polonia 31
EU - Europa 30
GR - Grecia 30
AR - Argentina 28
EC - Ecuador 28
CI - Costa d'Avorio 27
PH - Filippine 25
PE - Perù 24
AU - Australia 23
TW - Taiwan 23
RO - Romania 22
IL - Israele 18
MY - Malesia 18
TH - Thailandia 18
AT - Austria 17
HU - Ungheria 16
PT - Portogallo 16
UZ - Uzbekistan 15
IQ - Iraq 14
CZ - Repubblica Ceca 12
NO - Norvegia 11
SA - Arabia Saudita 11
PK - Pakistan 10
AE - Emirati Arabi Uniti 9
ZA - Sudafrica 9
DZ - Algeria 8
NZ - Nuova Zelanda 7
OM - Oman 7
RS - Serbia 7
SY - Repubblica araba siriana 7
DO - Repubblica Dominicana 6
EG - Egitto 6
IR - Iran 6
MA - Marocco 6
SI - Slovenia 5
VE - Venezuela 5
BG - Bulgaria 4
BZ - Belize 4
CR - Costa Rica 4
JM - Giamaica 4
LB - Libano 4
LT - Lituania 4
MT - Malta 4
TN - Tunisia 4
AZ - Azerbaigian 3
JO - Giordania 3
LV - Lettonia 3
NP - Nepal 3
PY - Paraguay 3
QA - Qatar 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
KE - Kenya 2
KW - Kuwait 2
LK - Sri Lanka 2
PA - Panama 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
FJ - Figi 1
Totale 10.146
Salva come PNG Salva come JPEG
Città #
Southend 669
Singapore 476
Fairfield 364
Ashburn 345
Chandler 276
Milan 205
San Jose 172
Beijing 166
Hong Kong 144
Seattle 95
Dallas 91
Los Angeles 89
Wilmington 84
Dublin 83
New York 74
Princeton 72
Shanghai 68
Council Bluffs 65
Frankfurt am Main 65
Guangzhou 65
Ann Arbor 63
Santa Clara 63
Redwood City 60
Toronto 59
Houston 54
Woodbridge 54
Jacksonville 52
Bengaluru 49
Ho Chi Minh City 48
Hanoi 47
Buffalo 38
Nanjing 38
Redmond 37
Helsinki 36
Lauterbourg 36
Tokyo 34
Dearborn 32
Rome 32
Cambridge 29
Des Moines 29
Phoenix 29
Jinan 28
Bogotá 27
Moscow 27
Paris 27
São Paulo 27
Abidjan 26
Boardman 26
Jakarta 26
Columbus 25
Mountain View 25
Istanbul 24
Berlin 23
Hefei 23
Munich 23
Bologna 22
Central 21
Chicago 21
Nanchang 21
The Dalles 21
Athens 20
Brussels 20
Madrid 19
Serra 19
Somerville 19
Lima 18
Montreal 18
Cangzhou 17
London 17
Sakarya 17
Santiago 17
Changsha 16
Chengdu 16
Falls Church 16
Hanover 16
Andover 15
Denver 15
Pillaro 15
Atlanta 14
New Delhi 14
Brescia 13
Hangzhou 13
Hebei 13
Turin 13
Warsaw 13
Zhengzhou 13
Barcelona 12
Düsseldorf 12
Shenyang 12
Shenzhen 12
Amsterdam 11
Debrecen 11
Haiphong 11
Mainz 11
Ottawa 11
Taipei 11
Brooklyn 10
Bühl 10
Curitiba 10
Dong Ket 10
Totale 5.620
Salva come PNG Salva come JPEG
Nome #
Prevention of orbitopathy by oral or intravenous steroid prophylaxis in short duration Graves’ disease patients undergoing radioiodine ablation : A prospective randomized control trial study 1.321
Efficacy profile and safety implications of very low dose Rituximab in patients with graves' orbitopathy 805
Incidence of elevation of serum thyroid-stimulating hormone during controlled ovarian hyperstimulation for in vitro fertilization 492
Therapy of endocrine disease : Endocrine dilemma : management of Graves' orbitopathy 479
Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy. 335
null 327
Primary Adrenal Insufficiency during Lenvatinib or Vandetanib and Improvement of Fatigue after Cortisone Acetate Therapy 316
Recombinant human TSH testing is a valuable tool for differential diagnosis of congenital hypothyroidism during L-thyroxine replacement 305
B cell activating factor (BAFF) and BAFF receptor expression in autoimmune and nonautoimmune thyroid diseases 283
The thyroid risk score (TRS) for nodules with indeterminate cytology 279
Different responses to chronic somatostatin analogues in patients with central hyperthyroidism 263
TBG deficiency: description of two novel mutations associated with complete TBG deficiency and review of the literature 261
Rituximab treatment in patients with active Graves' orbitopathy : effects on proinflammatory and humoral immune reactions 259
Monoallelic expression of mutant thyroid peroxidase allele causing total iodide organification defect 253
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe graves' orbitopathy : a randomized controlled study 237
Thyroid scintigraphy and perchlorate test after recombinant human TSH: a new tool for the differential diagnosis of congenital hypothyroidism during infancy 234
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients 231
Impact of estrogen and progesterone receptors expression on the clinical and molecular features of papillary thyroid cancer 223
Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy 213
Cardiovascular events and intensity of treatment in polycythemia vera 211
A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake 208
BRAF mutations in an Italian series of thyroid cancers 208
Gitelman’s sindrome : description of a new case in a family with RTH 207
A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy. 205
Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression 204
Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab : an open study 199
Radioiodine treatment of non-toxic multinodular goitre : effects of combination with lithium 198
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy 187
Analysis of a deiodinase 2 polymorphism (oRFa-Asp) in patients with Graves’ disease and controls : preliminary results 183
The long-term impact of controlled ovarian hyperstimulation on thyroid function 175
Small dose of rituximab for graves orbitopathy : new insights into the mechanism of action 173
New immunomodulators in the treatment of Graves' ophthalmopathy 172
Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy 171
Rituximab induces distinct intraorbital and intrathyroidal effects in one patient satisfactorily treated for graves' ophthalmopathy 169
Feasibility study for the introduction of a new treatment method for benign thyroid nodules in a teaching and research hospital 167
Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy 165
Thyroid volume and serum calcitonin changes during pregnancy 163
High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids 9
Totale 10.490
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.936
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.936
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021179 0 0 0 0 0 0 0 0 0 0 99 80
2021/2022932 81 49 53 71 69 40 89 62 134 81 64 139
2022/20231.103 128 139 75 119 96 160 50 78 109 41 48 60
2023/2024839 44 60 65 77 151 62 58 64 41 67 62 88
2024/20251.754 72 149 57 177 154 75 139 168 112 207 188 256
2025/20262.681 313 213 277 242 253 176 352 120 229 190 316 0
Totale 10.490